Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan

In Japan, medical costs are increasing annually, and the increase in national medical costs, particularly in the direct cost of managing adverse drug events, is high. An in-depth understanding of these costs is important for their reduction. This study aimed to calculate the direct cost of managing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hayato Katsuno, Tomoya Tachi, Takuya Matsuyama, Mayuko Sugioka, Satoshi Aoyama, Tomohiro Osawa, Yoshihiro Noguchi, Masahiro Yasuda, Chitoshi Goto, Takashi Mizui, Hitomi Teramachi
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
adverse drug event
direct cost
inpatient
older adult
outpatient
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/c56489980feb48b9bcfeae28f2cdf6b3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/c56489980feb48b9bcfeae28f2cdf6b3

Ejemplares similares